PGL4001 Versus Placebo in Uterine Myomas

NCT00755755 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Myomas

Interventions

DRUG: PGL4001 (ulipristal) and iron
DRUG: PGL4001 matching placebo and iron
DRUG: PGL4001 (ulipristal) and iron

Sponsor

PregLem SA